Divergent synthesis of fractionated Cannabis sativa extract led to multiple cannabinoids C-&O-glycosides with anti-proliferative/ anti-metastatic properties

Here, we present an interesting, previously unreported method for fractionating a particular class of cannabi-noids from the crude leaf extract of Cannabis sativa using HP-20 resins. In this study, we report a novel method of divergent synthesis of fractionated Cannabis sativa extract, which allows the generation of multiple cannabinoids C-and O-glycosides which react with the glycosyl donor 2,3,4,6-tetra-O-acetyl-D-mannosyl trichloroacetimidate (TAMTA) to create eight C-and O-beta-D-cannabinoids glycosides (COCG), which are separated by HPLC and whose structures are characterized by 1D, 2D NMR, and mass spectrometry. These glycosides exhibit improved anti-proliferative and anti-metastatic effects against numerous cancer cell lines in vitro and are more water-soluble and stable than their parent cannabinoids. The in vitro testing of the pure cannabinoids (1-4) and their C-& O-glycosides (1a-4a) and 1b-4b exhibited anti-proliferative and anti-metastatic activities against a panel of eight human cancer cell lines in contrast to their respective parent molecules. Different cancer cell lines' IC50 values varied significantly when their cell viability was compared. In addition to the others, compounds 2a, 3a, 4a, and 2b, 3b were highly potent, with IC50 values ranging from 0.74 mu M (3a) to 51.40 mu M (4a). Although 2a (1.42 mu M) and 3a (0.74 mu M) exhibited lower IC50 values in the MiaPaca-2 cell line than 4a (2.58 mu M). But, in addition to the comparable anti-clonogenic activity of 4a in MiaPaca-2 and Panc-1 cells, it manifested remarkable anti-invasive activity than either 2a or 3a. In contrast to 2a, 2b, 3a, and 3b and their respective parent compounds, 4a had substantial anti-invasive/anti-metastatic capabilities and possessed anti-proliferative activity. The effects of 4a treatment on MiaPaca-2 and Panc-1 cells include a dose-dependent increase in the expression of E-cadherin and a significant decrease in the expression of Zeb-1, Vimentin, and Snail1. Our results demonstrate that divergent synthesis of fractionated Cannabis sativa extract is a feasible and efficient strategy to produce a library of novel cannabinoid glycosides with improved pharmacological properties and potential anticancer benefits.